BIOLASE, Inc. (BIOLQ)

OTCMKTS · Delayed Price · Currency is USD

0.000001

0.00 (0.00%)

At close: Jun 18, 2026

-99.99% (1Y)

Market Cap	37.00 -100.0%
Revenue (ttm)	46.03M -7.4%
Net Income	-15.97M
EPS	-0.71
Shares Out	36.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,112
Open	0.000001
Previous Close	0.000001
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0128
Beta	0.07
Analysts	Strong Buy
Price Target	2.00 (+199,999,900.0%)
Earnings Date	n/a

About BIOLASE

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company provides Waterlase (all-tissue) systems for cutting soft and hard tissue; and diode (s... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1984

Employees 157

Stock Exchange OTCMKTS

Ticker Symbol BIOLQ

Full Company Profile

Financial Performance

In 2023, BIOLASE's revenue was $49.16 million, an increase of 1.45% compared to the previous year's $48.46 million. Losses were -$37.62 million, 30.4% more than in 2022.

Financial Statements